Skip to content

Lexicon Announces Pricing of Public Offering and Concurrent Private Placement

Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private Placement Background Image

Vinson & Elkins advised Lexicon Pharmaceuticals, Inc. in connection with an underwritten public offering of 16,843,600 shares of its common stock at a public offering price of $2.50 per share.

In addition to the shares being sold in the underwritten public offering, Lexicon has agreed to sell 17,156,400 shares of its common stock to raise gross proceeds of approximately $42.9 million in a concurrent private placement at $2.50 per share. The offering and private placement closed on August 1, 2022.

The V&E team was led by partner Dave Oelman, with assistance from counsel Zach Swartz and associates Shane Copelin, Nina Bhatia and Jake Lubenow.

About Vinson & Elkins
For more than a century, Vinson & Elkins has provided outstanding client service across important industries that drive the global economy. Built on a strong culture of collaboration across 12 offices worldwide, V&E lawyers are committed to excellence, offering clients decades of legal experience in handling transactions, investments, projects and disputes across the globe. Learn more by visiting www.velaw.com or follow us on Twitter @VinsonandElkins or connect with us on LinkedIn.

For more information, please speak with our media contacts.